Allergan acquires gene therapy company RetroSense Therapeutics LLC for $60M upfront cash.
Allergan plc. (NYSE:AGN), based in Dublin, Ireland, has announced the acquisition of Michigan-based gene therapy company RetroSense Therapeutics in an upfront all-cash based transaction for… Read More »Allergan acquires gene therapy company RetroSense Therapeutics LLC for $60M upfront cash.